September 08, 2014
Par Resumes Generic Precedex Shipment
Par announced that it has resumed shipping Dexmedetomidine HCl Injection, the generic version of Hospira's Precedex. This resumption is following the lifting of a restraining order that was issued in August at Hospira's request.
Precedex is an alpha-2 adrenergic agonist indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting, and for sedation of non-intubated patients prior to and/or during surgical and other procedures.
RELATED: Mylan Launches Generic Precedex
Dexmedetomidine HCl Injection is available in 200mcg/2mL single-use vials and are preservative-free.
For more information call (800) 828-9393 or visit ParPharm.com.